Arcturus Therapeutics Holdings Inc. Share Price
ARCTArcturus Therapeutics Holdings Inc. Stock Performance
Open $8.64 | Prev. Close $8.29 | Circuit Range N/A |
Day Range $8.09 - $8.64 | Year Range $8.06 - $23.95 | Volume 33,833 |
Average Traded $8.30 |
Arcturus Therapeutics Holdings Inc. Share Price Chart
About Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms includes LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate that is in phase 2 clinical trial for cystic fibrosis. Its product pipeline includes KOSTAIVE for the treatment of covid 19; ARCT-2138 (LUNAR-FLU), which is in phase 1 clinical trial for the treatment of seasonal influenza; ARCT-2304 (LUNAR-H5N1) that is in phase 1 clinical trial for the treatment of Pandemic Influenza; ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3 clinical trial; and ARCT-2303 for monovalent that is in Phase 3 clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.
Arcturus Therapeutics Holdings Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $8.64 | $8.15 | +0.00% |
12-Nov-25 | $8.64 | $8.15 | -5.73% |
11-Nov-25 | $9.09 | $8.64 | -1.65% |
10-Nov-25 | $8.74 | $8.79 | +0.92% |
07-Nov-25 | $8.09 | $8.71 | +5.26% |
06-Nov-25 | $8.48 | $8.28 | -4.00% |
05-Nov-25 | $8.95 | $8.62 | -3.09% |
FAQs on Arcturus Therapeutics Holdings Inc. Share Price
Can I buy Arcturus Therapeutics Holdings Inc. shares in India?
What is the share price of Arcturus Therapeutics Holdings Inc.?
What is the 5 year returns of Arcturus Therapeutics Holdings Inc.?
What are the high & low stock price of Arcturus Therapeutics Holdings Inc. today?
What is the 52-week high and low of Arcturus Therapeutics Holdings Inc. stock?